1. 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. (15th December 2022) Authors: Grigoropoulos, Ioannis; Tsioulos, Georgios; Kastrissianakis, Artemis; Shapira, Shiran; Arber, Nadir; Poulakou, Garyfallia; Syrigos, Konstantinos; Rapti, Vasiliki; Xynogalas, Ioannis; Leontis, Konstantinos; Ntousopoulos, Vasileios; Sakka, Vissaria; Gaga, Mina; Sardelis, Zafeiris; Fotiadis, Andreas... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Can steroids reverse the severe COVID‐19 induced "cytokine storm"?. Issue 11 (29th June 2020) Authors: Kolilekas, Lykourgos; Loverdos, Konstantinos; Giannakaki, Styliani; Vlassi, Lamprini; Levounets, Anastasia; Zervas, Eleftherios; Gaga, Mina Other Names: Luo Guangxiang (George) guestEditor.; Ly Hinh guestEditor.; Gao Shou‐Jiang guestEditor. Journal: Journal of medical virology Issue: Volume 92:Issue 11(2020) Page Start: 2866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗